Did you know that over one-fifth of the Ethiopian population—specifically 21.7%—are affected by Chronic Kidney Disease (CKD), often linked to conditions like diabetes and high blood pressure? This alarming statistic highlights the urgent need for proactive measures. But here’s where it gets controversial: many believe that with better prevention strategies, CKD could significantly be reduced or even avoided altogether.
Recently, a major step was taken to combat this health crisis. The Ethiopian Ministry of Health officially launched a new program aimed at preventing CKD, in partnership with global and local organizations such as AstraZeneca, Population Service International (PSI) Ethiopia, and Healthy Heart Africa (HHA). This initiative’s goal is to make kidney health more accessible within local communities by improving access to qualified healthcare professionals, establishing more efficient referral systems, and offering early diagnostic services.
Preventing non-communicable diseases like CKD hinges on lifestyle changes—reducing intake of fats, sugars, and salt, staying active, and limiting alcohol consumption. Dr. Dereje Duguma, Ethiopia’s State Minister of Health, emphasized that the government aims to tackle CKD by providing treatment twice each year to those at risk. The program also includes door-to-door screening efforts, the deployment of medical equipment, and ensuring a steady supply of medications. As Ruth Weldtensaye, Acting Country Representative for PSI Ethiopia, explained, “This initiative will build directly on Ethiopia’s existing primary healthcare system, embedding early detection of kidney disease into routine medical care.”
The overarching aim is clear: to ensure no patient is overlooked, to strengthen referral pathways, and to enhance the skills of healthcare workers across the country. This is a perfect example of translating policy into action—bringing preventative healthcare directly into communities in collaboration with AstraZeneca and the Ministry of Health.
And here’s where it might spark debate: is this approach enough, or are there still gaps that could hinder its success? Could focusing on early detection and lifestyle modifications truly curb the rising tide of CKD? What are your thoughts—do these initiatives have the potential to make a real difference, or are there challenges that might undermine their impact? Let’s discuss.
